Beta-Lactone Intermediate Synthesis via Mild Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing β-lactone intermediates for Orlistat synthesis are costly and not suitable for large-scale industrial production due to harsh reaction conditions and expensive reagents, particularly the use of DIBAL as a reductive agent at low temperatures.

Innovation Solution

A method involving reduction and oxidation steps using moderate reagents like dimethyl sulfide borane and pyridinium chlorochromate under basic conditions, followed by acylation and condensation with Lewis acid catalysis, which allows for a more economical and practical synthesis of β-lactone intermediates, reducing production costs and simplifying purification processes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If DIBAL reagent is used for reducing alkyl acid ester at low temperature (-78°C), then the reduction reaction can be completed, but the production cost increases and the reaction conditions become harsh

Engineering Contradiction:
Improvereduction reaction completionVSAvoidproduction cost and reaction conditions
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent changes the reaction parameters by replacing DIBAL reagent with borane dimethyl sulfide complex and sodium borohydride, and conducting the reaction at room temperature instead of -78°C. This parameter change resolves the contradiction by maintaining reduction reaction effectiveness while significantly lowering production cost and simplifying reaction conditions

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent substitutes expensive DIBAL reagent with cheaper alternatives (borane dimethyl sulfide complex and sodium borohydride). These cheaper reagents achieve the same reduction function without requiring expensive low-temperature equipment, thus resolving the cost issue while maintaining reaction reliability

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Productivity

If method (1) is used for constructing β-lactone intermediate through condensation and cyclization, then the number of reaction steps is reduced, but expensive reagents and harsh conditions are still required

Engineering Contradiction:
Improvenumber of reaction stepsVSAvoidreagent cost and reaction conditions
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent modifies the reaction parameters by using borane dimethyl sulfide complex and sodium borohydride instead of expensive reagents, and conducting reactions at room temperature. This maintains the advantage of fewer reaction steps while eliminating the disadvantage of high reagent cost and harsh conditions

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces borane dimethyl sulfide complex as an intermediary reagent that facilitates the reduction reaction under milder conditions. This intermediary enables the condensation and cyclization to proceed efficiently without requiring expensive reagents or harsh conditions, thus resolving the contradiction between productivity and ease of manufacture

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method achieves a yield of over 30% β-lactone intermediate with high purity, suitable for mass industrial production, and eliminates the need for harsh conditions and expensive reagents, making it economically viable.

Implementation Method 1

reducing a substance represented by formula (II) to form a substance represented by formula (III) using a reduction reagent, wherein the reduction reagent is selected from the group consisting of dimethyl sulfide borane, dimethyl sulfide borane/sodium borohydride

Methodology Applied
Scientific EffectReduction: Reduction

Implementation Method 2

oxidizing the substance represented by formula (III) to form a substance represented by formula (IV) using an oxidation reagent under basic condition

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 3

reacting the substance obtained in the step a) with the substance obtained in the step b) under catalytic condition of Lewis acid to form a substance represented by formula (VII)

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentEP2280007B1The preparation method of (3s,4s)-3-hexyl-4-((r)-2-hydroxytridecyl)-oxetan-2-one and the product of that method
Publication Date: 2015.04.29 ZEIN BIOTECHNOLOGY CO LTD
  • EP2280007B1 patent drawing
  • EP2280007B1 patent drawing
  • EP2280007B1 patent drawing

AI summary

The present invention relates to a method for the preparation of (3S,4S)-3-hexyl-4-((R)-2-hydroxytridecyl)-oxetan-2-one and a product of the method. The method includes the following steps: a) reducing a substance represented by formula (II) to obtain a substance represented by formula (III), and then oxidizing the substance represented by formula (III) to form a substance represented by formula (IV); b) acylating n-octanoic acid to obtain n-octanoyl chloride using thionyl dichloride, then condensing the obtained n-octanoyl chloride with 2-mercapto-pyridine under basic condition to form a substance represented by formula (V), and then converting the substance represented by formula (V) to a substance represented by formula (VI); c) reacting the substance obtained in the step a) with the substance obtained in the step b) under catalytic condition of Lewis acid to generate a substance represented by formula (VII), and then reacting with a Lewis acid. The meanings of the signs in these formulas are the same as those in the description.